![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Multi-Target DAA Therapy is Associated with Superior Immunologic Recovery in HIV/HCV Co-Infected Patients
|
|
|
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
S. SHRIVASTAVA1, M. BHATTA1,2, H. WARD1,2, R. LEE1, E. ROSENTHAL1, H. MASUR2, S. KOTTILIL1, and E. WILSON1
1 Institute for Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201
2 Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892
![0607171](../images/060717/060717-2/0607171.gif)
![0607172](../images/060717/060717-2/0607172.gif)
![0607173](../images/060717/060717-2/0607173.gif)
![0607174](../images/060717/060717-2/0607174.gif)
![0607175](../images/060717/060717-2/0607175.gif)
![0607176](../images/060717/060717-2/0607176.gif)
![0607177](../images/060717/060717-2/0607177.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|